Clinical Trials Browser

Phase 2 × Central Nervous System Neoplasms × Gefitinib × Clear all

NCT00025675 2018-06-26

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

NCT00016991 2013-06-20

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse

Phase 2 Completed

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma